PT

Peter Turecek

BI Baxter International: 44 patents #12 of 2,334Top 1%
BS Baxter Healthcare Sa: 43 patents #8 of 1,132Top 1%
BI Baxalta Incorporated: 26 patents #3 of 230Top 2%
IA Immuno Aktiengesellschaft: 17 patents #4 of 75Top 6%
BA Baxter Aktiengesellschaft: 14 patents #4 of 86Top 5%
TL Takeda Pharmaceutical Company Limited: 9 patents #168 of 1,531Top 15%
BG Baxter Innovations Gmbh: 4 patents #4 of 22Top 20%
NT Nektar Therapeutics: 4 patents #65 of 250Top 30%
SB Stichting Sanquin Bloedvoorziening: 3 patents #6 of 43Top 15%
LL Lipoxen Technologies Limited: 2 patents #10 of 23Top 45%
BH Baxter Healthcare: 1 patents #9 of 68Top 15%
Overall (All Time): #10,349 of 4,157,543Top 1%
118
Patents All Time

Issued Patents All Time

Showing 25 most recent of 118 patents

Patent #TitleCo-InventorsDate
12178861 Stabilized liquid and lyophilized ADAMTS13 formulations Peter Matthiessen, Hans-Peter Schwarz 2024-12-31
11564992 Nucleophilic catalysts for oxime linkage Juergen Siekmann, Stefan Haider, Hanspeter Rottensteiner 2023-01-31
11564979 Stabilized liquid and lyophilized ADAMTS13 formulations Peter Matthiessen, Hans-Peter Schwarz 2023-01-31
11197916 Lyophilized recombinant VWF formulations Kurt Schnecker, Eva Haidweger 2021-12-14
11191837 Recombinant VWF formulations Peter Matthiessen, Hans-Peter Schwarz, Kurt Schnecker 2021-12-07
11191813 Lyophilized recombinant VWF formulations Kurt Schnecker, Eva Haidweger 2021-12-07
11160850 Compositions of human prothrombin and activated factor X for improving hemostasis in the treatment of bleeding disorders Michael Dockal, Sabine Knappe, Susanne Till, Friedrich Scheiflinger 2021-11-02
11040109 Blood coagulation protein conjugates Juergen Siekmann, Stefan Haider, Hanspeter Rottensteiner 2021-06-22
11020458 Factor VIII polymer conjugates Juergen Siekmann 2021-06-01
10900979 Methods for testing effectiveness of a von Willebrand factor used in treating von Willebrand disease (VWD) Katalin Varadi, Hanspeter Rottensteiner, Hans-Peter Schwarz, Jutta Schreiner 2021-01-26
10772968 Glycopolysialylation of non-blood coagulation proteins Sanjay Jain, Gregory Gregoriadis, Archana Dwivedi, Srijit Nath, Juergen Siekmann +2 more 2020-09-15
10758599 Stabilized liquid and lyophilized ADAMTS13 formulations Peter Matthiessen, Hans-Peter Schwarz 2020-09-01
10576160 Nucleophilic catalysts for oxime linkage Juergen Siekmann, Stefan Haider, Hanspeter Rottensteiner 2020-03-03
10414793 Nucleophilic catalysts for oxime linkage Stefan Haider, Andreas Ivens, Hanspeter Rottensteiner, Juergen Siekmann, Oliver Zoechling 2019-09-17
10350301 Blood coagulation protein conjugates Juergen Siekmann, Stefan Haider, Hanspeter Rottensteiner 2019-07-16
10251941 Factor VIIa-polysialic acid conjugates having prolonged in vivo half-life Juergen Siekmann, Friedrich Scheiflinger, Michel Canavaggio 2019-04-09
10238720 Stabilized liquid and lyophilized ADAMTS13 formulations Peter Matthiessen, Hans-Peter Schwarz 2019-03-26
10232022 Lyophilized recombinant VWF formulations Kurt Schnecker, Eva Haidweger 2019-03-19
10209263 Methods of measuring adamts 13 activity Katalin Varadi, Hanspeter Rottensteiner, Hans-Peter Schwarz, Jutta Schreiner 2019-02-19
9937244 Stabilized liquid and lyophilized ADAMTS13 formulations Peter Matthiessen, Hans-Peter Schwarz 2018-04-10
9795683 Glycopolysialylation of non-blood coagulation proteins Sanjay Jain, Gregory Gregoriadis, Archana Dwivedi, Srijit Nath, Juergen Siekmann +2 more 2017-10-24
9731024 Nucleophilic catalysts for oxime linkage Juergen Siekmann, Stefan Haider, Hanspeter Rottensteiner 2017-08-15
9587249 Models of thrombotic thrombocytopenic purpura and methods of use thereof Hans-Peter Schwarz, Eva-Maria Muchitsch 2017-03-07
9572778 Stabilized liquid and lyophilized ADAMTS13 formulations Peter Matthiessen, Hans-Peter Schwarz 2017-02-21
9547016 Method and compositions for specifically detecting physiologically acceptable polymer molecules Juergen Siekmann, Alfred Weber, Herbert Gritsch, Katalin Varadi, Susanne Vejda 2017-01-17